Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life Study
- DOI
- 10.1097/mjt.0000000000002171
- Published
- 2026-07-23
- Container
- American Journal of Therapeutics
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/mjt.0000000000002171,
title = {Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life Study},
author = {Antonio Tursi and Giammarco Mocci and Franco Scaldaferri and Daniele Napolitano and Federica Gaiani and Gianluigi De' Angelis and Davide Giuseppe Ribaldone and Eleonora Schillaci and Edoardo V. Savarino and Caterina D. E. Barba and Emanuele Bendia and Laura Bolognini and Daniele Balducci and Claudia Quatraccioni and Francesco Martini and Michele Montori and Giovanni Maconi and Giovanni Cataletti and Alessandro Massari and Elena Del Zanna and Francesco Costa and Linda Ceccarelli and Antonietta G. Gravina and Raffaele Pellegrino and Giorgia Bodini and Andrea Pasta and Manuela Marzo and Agnese Miranda and Antonio Cuomo and Laura Donnarumma and Giovanni Lombardi and Marta Patturelli and Mariaelena Serio and Antonella Scarcelli and Giuseppe Pranzo and Chiara Maria Palmisano and Rocco Spagnuolo and Francesco Luzza and Domenico Morano and Giuliana Vespere and Silvia Sedda and Leonardo D. E. Luca and Walter Elisei and Rita Monterubbianesi and Michela Di Fonzo and Libera Fanigliulo and Roberta Pica and Claudio Cassieri and Andrea Cocco and Elisa Stasi and Laurino Grossi and Lorenzo Bertani and Fabio Cortellini and Simona Piergallini and Patrizio Scarozza and Girolamo Bevevino and Giulia Zerboni and Federico Iacopini and Stefano Rodino' and Ladislava Sebkova and Davide Checchin and Francesca Lamboglia and Francesco Ferrara and Nicola Della Valle and Raffaele Colucci and Francesco Bachetti and Domenico Catarella and Dario D'agostino and Elisabetta D. I. Bartolo and Ileana Luppino and Mario Erboso and Giulia Rocco and Carlotta Sacchi and Costantino Zampaletta and Giacomo Forti and Serafina Fiorella and Gabrio Bassotti and Elisabetta Antonelli and Caterina Mucherino and Elvira D'Antonio and Laura Montesano and Maurizio Giovannone and Giuseppina Vincoli and Alessandro Gigliozzi and Berardino D'Ascoli and Marina Rizzi and Pietro Capone and Giovanni Aragona and Patrizia Perazzo and Leonardo Allegretta and Paolo Tonti and Viviana Neve and Cristiano Pagnini and Antonio Grandolfo and Francesco Gatti and Antongiulio Bucci and Massimiliano Rizzi and Marcello Picchio and Francesca Maria Onidi and Paolo Usai Satta and Alfredo Papa},
year = {2026},
journal = {American Journal of Therapeutics},
doi = {10.1097/mjt.0000000000002171},
url = {https://doi.org/10.1097/mjt.0000000000002171}
}RIS
TY - JOUR TI - Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life Study AU - Antonio Tursi AU - Giammarco Mocci AU - Franco Scaldaferri AU - Daniele Napolitano AU - Federica Gaiani AU - Gianluigi De' Angelis AU - Davide Giuseppe Ribaldone AU - Eleonora Schillaci AU - Edoardo V. Savarino AU - Caterina D. E. Barba AU - Emanuele Bendia AU - Laura Bolognini AU - Daniele Balducci AU - Claudia Quatraccioni AU - Francesco Martini AU - Michele Montori AU - Giovanni Maconi AU - Giovanni Cataletti AU - Alessandro Massari AU - Elena Del Zanna AU - Francesco Costa AU - Linda Ceccarelli AU - Antonietta G. Gravina AU - Raffaele Pellegrino AU - Giorgia Bodini AU - Andrea Pasta AU - Manuela Marzo AU - Agnese Miranda AU - Antonio Cuomo AU - Laura Donnarumma AU - Giovanni Lombardi AU - Marta Patturelli AU - Mariaelena Serio AU - Antonella Scarcelli AU - Giuseppe Pranzo AU - Chiara Maria Palmisano AU - Rocco Spagnuolo AU - Francesco Luzza AU - Domenico Morano AU - Giuliana Vespere AU - Silvia Sedda AU - Leonardo D. E. Luca AU - Walter Elisei AU - Rita Monterubbianesi AU - Michela Di Fonzo AU - Libera Fanigliulo AU - Roberta Pica AU - Claudio Cassieri AU - Andrea Cocco AU - Elisa Stasi AU - Laurino Grossi AU - Lorenzo Bertani AU - Fabio Cortellini AU - Simona Piergallini AU - Patrizio Scarozza AU - Girolamo Bevevino AU - Giulia Zerboni AU - Federico Iacopini AU - Stefano Rodino' AU - Ladislava Sebkova AU - Davide Checchin AU - Francesca Lamboglia AU - Francesco Ferrara AU - Nicola Della Valle AU - Raffaele Colucci AU - Francesco Bachetti AU - Domenico Catarella AU - Dario D'agostino AU - Elisabetta D. I. Bartolo AU - Ileana Luppino AU - Mario Erboso AU - Giulia Rocco AU - Carlotta Sacchi AU - Costantino Zampaletta AU - Giacomo Forti AU - Serafina Fiorella AU - Gabrio Bassotti AU - Elisabetta Antonelli AU - Caterina Mucherino AU - Elvira D'Antonio AU - Laura Montesano AU - Maurizio Giovannone AU - Giuseppina Vincoli AU - Alessandro Gigliozzi AU - Berardino D'Ascoli AU - Marina Rizzi AU - Pietro Capone AU - Giovanni Aragona AU - Patrizia Perazzo AU - Leonardo Allegretta AU - Paolo Tonti AU - Viviana Neve AU - Cristiano Pagnini AU - Antonio Grandolfo AU - Francesco Gatti AU - Antongiulio Bucci AU - Massimiliano Rizzi AU - Marcello Picchio AU - Francesca Maria Onidi AU - Paolo Usai Satta AU - Alfredo Papa PY - 2026 JO - American Journal of Therapeutics DO - 10.1097/mjt.0000000000002171 UR - https://doi.org/10.1097/mjt.0000000000002171 ER -
APA
Tursi, A., Mocci, G., Scaldaferri, F., Napolitano, D., Gaiani, F., Angelis, G. D., Ribaldone, D. G., Schillaci, E., Savarino, E. V., Barba, C. D. E., Bendia, E., Bolognini, L., Balducci, D., Quatraccioni, C., Martini, F., Montori, M., Maconi, G., Cataletti, G., Massari, A., Zanna, E. D., Costa, F., Ceccarelli, L., Gravina, A. G., Pellegrino, R., Bodini, G., Pasta, A., Marzo, M., Miranda, A., Cuomo, A., Donnarumma, L., Lombardi, G., Patturelli, M., Serio, M., Scarcelli, A., Pranzo, G., Palmisano, C. M., Spagnuolo, R., Luzza, F., Morano, D., Vespere, G., Sedda, S., Luca, L. D. E., Elisei, W., Monterubbianesi, R., Fonzo, M. D., Fanigliulo, L., Pica, R., Cassieri, C., Cocco, A., Stasi, E., Grossi, L., Bertani, L., Cortellini, F., Piergallini, S., Scarozza, P., Bevevino, G., Zerboni, G., Iacopini, F., Rodino', S., Sebkova, L., Checchin, D., Lamboglia, F., Ferrara, F., Valle, N. D., Colucci, R., Bachetti, F., Catarella, D., D'agostino, D., Bartolo, E. D. I., Luppino, I., Erboso, M., Rocco, G., Sacchi, C., Zampaletta, C., Forti, G., Fiorella, S., Bassotti, G., Antonelli, E., Mucherino, C., D'Antonio, E., Montesano, L., Giovannone, M., Vincoli, G., Gigliozzi, A., D'Ascoli, B., Rizzi, M., Capone, P., Aragona, G., Perazzo, P., Allegretta, L., Tonti, P., Neve, V., Pagnini, C., Grandolfo, A., Gatti, F., Bucci, A., Rizzi, M., Picchio, M., Onidi, F. M., Satta, P. U., & Papa, A. (2026). Effectiveness and Safety of Risankizumab in Crohn Disease After Failure of a First Line of Advanced Therapy: A Long-Term, Real-Life Study. American Journal of Therapeutics. https://doi.org/10.1097/mjt.0000000000002171
Source records
- crossref · retrieved 2026-09-26T13:21:09.363Z